News in the Life Sciences Industry

SHANGHAI, Nov. 13, 2020 /PRNewswire/ -- Despite the global market uncertainties caused by the COVID-19 pandemic, the confidence and interest that foreign companies have in the Chinese market appear unchanged, with the value of tentative deals reached for one-year purchases of goods and services... Read more ››

ROME, Nov. 12, 2020 /PRNewswire/ -- Angelini Pharma and Sunovion Pharmaceutical Europe announced today the European Medicines Agency (EMA) approval for Latuda (lurasidone), with the indication for the treatment of Adolescent Schizophrenia in patients starting from 13 years of age. Latuda becomes... Read more ››

BANGKOK, Nov. 12, 2020 /PRNewswire/ -- B. Braun Thailand won the coveted 'Best Companies to Work for in Asia 2020 Award' by HR Asia on 16(th) October 2020.

STUTTGART, Germany, Nov. 11, 2020 /PRNewswire/ -- A new, inventive cutting-edge therapy (PIPAC - Pressurized IntraPeritoneal Aerosol Chemotherapy) is bringing hope to millions of cancer patients across the globe -- including Asia. This treatment is performed using Capnomed's uniquely designed,... Read more ››

HAMBURG, Germany, Nov. 10, 2020 /PRNewswire/ -- Indivumed announced today the launch of its new, AI-integrated Advanced Data Analytics Platform which will accelerate drug targets and diagnostics discoveries. In the past six months, Indivumed has built an ensemble of cutting-edge technologies... Read more ››

CHEMNITZ, Germany, Nov. 10, 2020 /PRNewswire/ -- 3D-Micromac AG, the industry leader in laser micromachining and roll-to-roll laser systems for the semiconductor, photovoltaic, medical device and electronics markets, today introduced the first industrial selective laser annealing system for magnetic... Read more ››

ABBOTT PARK, Ill., Nov. 10, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the IonicRF(TM) Generator - a new device recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous... Read more ››

Digital surgery pioneer names prominent medical experts to guide pan-European commercialization efforts

BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica... Read more ››

SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into in July 2019... Read more ››

First randomized clinical trial demonstrating that CTC count may help personalize treatment choices